COGT
Price
$7.57
Change
+$0.04 (+0.53%)
Updated
May 6, 6:59 PM EST
Earnings call today
SNDX
Price
$22.50
Change
+$0.45 (+2.04%)
Updated
May 6, 6:59 PM EST
One day until earnings call
Ad is loading...

COGT vs SNDX

Header iconCOGT vs SNDX Comparison
Open Charts COGT vs SNDXBanner chart's image
Cogent Biosciences
Price$7.57
Change+$0.04 (+0.53%)
Volume$480.74K
CapitalizationN/A
Syndax Pharmaceuticals
Price$22.50
Change+$0.45 (+2.04%)
Volume$232.15K
CapitalizationN/A
View a ticker or compare two or three
COGT vs SNDX Comparison Chart

Loading...

COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
COGT vs. SNDX commentary
May 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and SNDX is a Hold.

COMPARISON
Comparison
May 07, 2024
Stock price -- (COGT: $7.57 vs. SNDX: $22.50)
Brand notoriety: COGT and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 71% vs. SNDX: 44%
Market capitalization -- COGT: $723.79M vs. SNDX: $1.91B
COGT [@Biotechnology] is valued at $723.79M. SNDX’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $547.77B to $0. The average market capitalization across the [@Biotechnology] industry is $2.6B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 2 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 2 green, 3 red.
According to our system of comparison, SNDX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 7 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 7 bullish, 2 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COGT is a better buy in the short-term than SNDX.

Price Growth

COGT (@Biotechnology) experienced а +12.82% price change this week, while SNDX (@Biotechnology) price change was +5.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.61%. For the same industry, the average monthly price growth was -3.41%, and the average quarterly price growth was +64.25%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2024.

SNDX is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+3.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for COGT with price predictions.
OPEN
A.I.dvisor published
a Summary for SNDX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SNDX($1.91B) has a higher market cap than COGT($724M). COGT YTD gains are higher at: 28.741 vs. SNDX (2.036).
COGTSNDXCOGT / SNDX
Capitalization724M1.91B38%
EBITDAN/AN/A-
Gain YTD28.7412.0361,412%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
COGT vs SNDX: Fundamental Ratings
COGT
SNDX
OUTLOOK RATING
1..100
1250
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10034
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4747
P/E GROWTH RATING
1..100
1005
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (83) in the Miscellaneous industry is in the same range as SNDX (85) in the Biotechnology industry. This means that COGT’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Profit vs Risk Rating (34) in the Biotechnology industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that SNDX’s stock grew significantly faster than COGT’s over the last 12 months.

SNDX's SMR Rating (96) in the Biotechnology industry is in the same range as COGT (98) in the Miscellaneous industry. This means that SNDX’s stock grew similarly to COGT’s over the last 12 months.

SNDX's Price Growth Rating (47) in the Biotechnology industry is in the same range as COGT (47) in the Miscellaneous industry. This means that SNDX’s stock grew similarly to COGT’s over the last 12 months.

SNDX's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that SNDX’s stock grew significantly faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTSNDX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 8 days ago
85%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 4 days ago
76%
View a ticker or compare two or three
Ad is loading...
COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOCKX21.080.43
+2.08%
Fidelity OTC K
CHCRX9.340.11
+1.19%
AB Discovery Growth R
BAFFX38.000.38
+1.01%
Brown Advisory Flexible Equity Inst
TARZX21.320.19
+0.90%
Third Avenue Real Estate Value Z
BRKRX13.330.08
+0.60%
MFS Blended Research Em Mkts Eq R1

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SNDX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+0.53%
SNDX - COGT
51%
Loosely correlated
+2.04%
BMEA - COGT
44%
Loosely correlated
-0.73%
KROS - COGT
42%
Loosely correlated
-0.51%
DSGN - COGT
39%
Loosely correlated
-1.88%
XFOR - COGT
37%
Loosely correlated
+4.35%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+0.87%
NTLA - SNDX
46%
Loosely correlated
+1.42%
RAPT - SNDX
45%
Loosely correlated
+2.52%
RNA - SNDX
45%
Loosely correlated
+3.40%
VCYT - SNDX
45%
Loosely correlated
+0.79%
NRIX - SNDX
44%
Loosely correlated
+0.39%
More